Skip to main content
. 2021 May 10;43(1):830–839. doi: 10.1080/0886022X.2021.1906701

Table 1.

Altered bioactions of furosemide in critically ill patients with acute kidney injury.

Target abnormality Mechanism References
Hypoalbuminemia Impaired furosemide delivery to nephron 23,24
Loss of epithelial cell polarity Redistribution of Na/K + ATPase, impairing secondary active transport of organic acid. 25
Oliguria Toxic plasma levels of furosemide 26
Uremic organic acids accumulation Competiton with furosemide at the OAT1/OAT3 transporter site 27,28
Severe metabolic acidosis Competiton with furosemide at the OAT1/OAT3 transporter site 27,28
Elevated OAT1/OAT3 (+/−OAT4) transporter secretion in urine Tubular damage and destruction 29
Vasopressin administration Increase expression of NKCC2 transporter and promote insertion into TAL of loop of Henle 18,30
Cephalosporin administration Competition with furosemide at the OAT1/OAT3 transporter site 27,28